mortality/aging
• in mice infected with MHV-3 compared with infected wild-type mice
|
immune system
• reduced refined NK progenitor cells, but not pre-NKPs in the bone marrow
|
• a reduction in CD11b+CD27- and/or CD11b+CD27+ NK cells with increased CD11b-CD27+ NK cells indicating reduced maturation
|
• in the liver
|
• against Yac-1 in vitro
|
• increased CD11b-CD27+ NK cells with a reduction in CD11b+CD27- and/or CD11b+CD27+ NK cells indicating reduced maturation
|
• reduced NK cell activation in mice infected with MHV-3 compared with infected wild-type mice
• increased proliferation of CD11b- or CD11b+ NK cells in the bone marrow and spleen
• increased proliferation in response to IL15 stimulation
• NK cells stimulated with IL12 and IL18 exhibit decreased effector function compared with wild-type cells
|
• against Yac-1 in vitro
|
• mice infected with MHV-3 exhibit alleviated liver damage (reduced alanine and asparagine amino transferase), reduced NK cell activation and improved survival compared with wild-type mice
|
• in mice infected with MHV-3 compared with infected wild-type mice
|
homeostasis/metabolism
• in mice infected with MHV-3 compared with infected wild-type mice
|
• in mice infected with MHV-3 compared with infected wild-type mice
|
hematopoietic system
• reduced refined NK progenitor cells, but not pre-NKPs in the bone marrow
|
• a reduction in CD11b+CD27- and/or CD11b+CD27+ NK cells with increased CD11b-CD27+ NK cells indicating reduced maturation
|
• in the liver
|
• against Yac-1 in vitro
|
• increased CD11b-CD27+ NK cells with a reduction in CD11b+CD27- and/or CD11b+CD27+ NK cells indicating reduced maturation
|
• reduced NK cell activation in mice infected with MHV-3 compared with infected wild-type mice
• increased proliferation of CD11b- or CD11b+ NK cells in the bone marrow and spleen
• increased proliferation in response to IL15 stimulation
• NK cells stimulated with IL12 and IL18 exhibit decreased effector function compared with wild-type cells
|
• against Yac-1 in vitro
|